Caffeine is an Indirect Anti-Inflammatory Drug Interleukin-1β production is regulated by inflammasomes, a very large protein complex commonly associated with inflammation and pyroptosis. As the human body ages and accumulates metabolites, the inflammasome interacts with them and is primed for
December 2016: The Antibody Update
Merck’s Ebola Vaccine is 100% Effective An extremely effective Ebola virus vaccine created by Merck was recently tested in Guinea with 100% effectiveness. Though the vaccine is late for the worst part of the infection, the results are so promising
November 2016: The Antibody Update
China Perform First Injection of CRISPR Modified Cells into a Person Use of CRISPR-Cas9 in human cells for treatment of disease has been a controversial topic amongst scientists since the discovery of the powerful gene editing tool. In this clinical
October 2016: The Antibody Update
The Nobel Prize in Medicine was Awarded to Yoshinori Ohsumi for His Work on Autophagy Autophagy is the cellular process that regulates a cells ability to degrade parts of itself that must be replaced. Yoshinori Ohsumi’s work in autophagy has proven to
September 2016: The Antibody Update From ProSci
ProSci’s top news picks for September 2016 include a paper on a novel monoclonal antibody against parenchymal amyloid-beta for the treatment of Alzheimer’s Dementia, a scientist using CRISPR for gene editing of embryos, and an update on the discussion of
August 2016: The Antibody Update from ProSci
ProSci’s top news picks for August 2016 include a study on T-cell activity inside tumor tissue, the potential effects of Zika virus in adults, and mRNA therapeutics. T-cells Run
“Let’s Make America the Country That Cures Cancer Once and For All”
During the 2016 State of the Union Address, President Obama called attention to a myriad of issues currently plaguing Americans. One of the many initiatives President Obama announced in response was a “moonshot” to cure cancer, referencing the flood of
Searching for the Heart of the Problem: Antibodies to Cardiac Myosin Binding Protein
ProSci works with Dr. Sadayappan to create a set of custom antibodies used to study cardiomyopathy. Cardiac Myosin Binding Protein-C (cMyBP-C) is a protein present in cardiac muscle that has been shown to affect the organizational structure of the muscle